Paul C. Anderson
Director Técnico/Científico/I+D en Inception IBD, Inc. .
Cargos activos de Paul C. Anderson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - | - |
| Director Técnico/Científico/I+D | 10/12/2015 | - |
Historial de carrera de Paul C. Anderson
Antiguos cargos conocidos de Paul C. Anderson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2011 | - |
| The Chemical Institute of Canada | Corporate Officer/Principal | - | - |
Syndexa Pharmaceuticals Corp.
 Syndexa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Syndexa Pharmaceuticals Corp. developed novel medicines for the treatment and prevention of metabolic diseases. The company was founded in 2005 and was headquartered in Watertown, MA. | Corporate Officer/Principal | 17/12/2009 | - |
Formación de Paul C. Anderson.
| University of Alberta | Doctorate Degree |
| University of Western Ontario | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Canadá | 4 |
Operativa
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| The Chemical Institute of Canada | |
Syndexa Pharmaceuticals Corp.
Syndexa Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Syndexa Pharmaceuticals Corp. developed novel medicines for the treatment and prevention of metabolic diseases. The company was founded in 2005 and was headquartered in Watertown, MA. | Health Technology |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Paul C. Anderson
- Experiencia
